SoftBank Vision Fund 2

With roughly $56B under management, SoftBank Vision Fund 2 ranks among the active investors in the AI space. That capital is deployed across their portfolio of AI-focused bets.

Across their portfolio, SoftBank Vision Fund 2 has consistently backed companies in AI, Health, Mobility. These focus areas reflect where the firm sees the strongest risk-adjusted returns in AI.

Awaira currently tracks 2 companies in SoftBank Vision Fund 2's portfolio. The actual number may be higher, as some early-stage investments are not publicly disclosed.

The firm's sweet spot is Late Stage investing. That said, strong conviction deals can pull them into earlier or later rounds depending on the company.

The most notable deal on record for SoftBank Vision Fund 2 is SoftBank Vision Fund 2 is a growth-stage investment firm founded in 2021, headquartered in Japan, managing approximately $56B in assets under management. The firm concentrates on AI, Health, Mobility, deploying capital primarily at the late stage level. Notable AI portfolio companies include AutoStore, Mapbox. SoftBank Vision Fund 2 has participated in 39 funding rounds tracked by Awaira, deploying capital across AI, Health, Mobility sectors. The firm's investment strategy emphasizes AI applications in healthcare and life sciences. Awaira assigns SoftBank Vision Fund 2 an investor score of 82/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. SoftBank Vision Fund 2 evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including AutoStore, Mapbox reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.. It is the kind of investment that defines a fund's reputation in the AI ecosystem.